The first successful human renal transplant was performed between identical twins in 1954.1 As the transplanted kidney was an isograft, and thus not recognised as foreign tissue by the recipient, rejection did not occur. Since that time, it has become apparent that renal allografts obtained from living related donors have considerably better chances of survival than allografts from cadavers. This finding has stimulated many investigators to study the genetic factors that influence graft survival.
More than 20 years ago, Dausset in Paris,2 van Rood et al in Leiden,3 and Payne and Rolfs in San Francisco,4 demonstrated that sera from multiplytransfused patients or from multiparous women were capable of agglutinating leucocytes from some, but not all, normal subjects. Thus it was appreciated that nucleated cells have an antigen system separate from the recognised ABO red cell antigens. In 1967 this new system was designated HLA (H = Human, L = Leucocyte, and A for the first system discovered). During the intervening years it has been shown that most cells of the body, including T lymphocytes and platelets, possess three series of antigens, HLA-A, -B, and -C antigens, whereas the D and the closely-linked DR antigens are expressed on relatively few cell types, principally on B lymphocytes, monocytes, and macrophages. HLA-A and -B antigens are reasonably well characterised. HLA-D and -DR antigens are, however, less well defined but
The gene loci for all these HLA antigens are located on the short arm of the human chromosome 6 . As the genes are co-dominant, each cell expresses on its surface two antigens from each series, one inherited from the father and the other from the mother. The genes for factor B and both C2 and C4 components of the complement cascade are also located on chromosome 6 Currently, one-year allograft survival rates are approximately 60% although there is a considerable variation between different transplant centres. As immunological rejection remains the single most important cause of graft failure, it is essential that the recipient's immune response be modified if graft survival rates are to improve. Pretransplant blood transfusions clearly achieve this, although their mechanism of action remains obscure. At the present time it would appear that matching recipients and donors for HLA-DR antigens may also produce significant increases in graft survival rates and moreover prove technically possible in the limited time available before cadaver renal transplantation.
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Cherchez les femmes (or the personal touch in the laboratory)
A recent development in the prenatal diagnosis of neural tube defects has been the discovery that the qualitative assay of amniotic fluid cholinesterase and acetylcholinesterase (AChE) may be an even better diagnostic tool than -fetoprotein. ' The procedure can be broken down basically into three steps: (1) preparation of the solutions, (2) gel making and the electrophoresis, and (3) enzyme localisation. EXPERIMENT 
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M did steps 1 and 3, B did step 2. Result: success.
Conclusion: B had no problem with gel making and electrophoresis. EXPERIMENT 10 B did step 1, M did steps 2 and 3. Result: success.
Conclusion: B had no problem with preparation of solutions.
It appeared, therefore, that the error was occurring
